Inflammatory myopathies

Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study

Rheumatology (Oxford)Published Cross-sectional study

Authors' conclusion

We identified marked regional treatment disparities in a global cohort of IIM.

Study context

Population
Respondents with IIM (DM, PM, IBM, ASSD, IMNM, OM) to the international COVAD e-survey, 94 countriesof 18,851 respondents
Participants
1,418 respondents
Outcome
Current treatments for IIM and interregional differences (by continent, GNI, IIM subtype and organ involvement)
Methodological detailsancillary analysis of the COVAD e-survey, international online survey, multivariable binary logistic regressions
  • Ancillary analysis of the COVAD e-survey
  • International online survey
  • Multivariable binary logistic regressions

Main finding

As reported in the abstract

Treatment categories used

IS

49.4%

CS

38.5%

IM

13.8%

IVIG

9.4%

Observational data: associations, not effects.

Further findings

Most common IIM subtypes

DM
32.4%
IBM
24.5%
OM
15.8%

Original publication

Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study. Rheumatology (Oxford). Published 25 May 2023. doi:10.1093/rheumatology/kead250

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.